YAZ / Yasmin / Ocella / Gianvi / Beyaz / Safyral
Blood Clots • Pulmonary Embolism (PE) • Deep Vein Thrombosis (DVT) • Stroke • Heart Attack • Death
Gianvi (Generic YAZ), Beyaz, And Safyral Causing Blood Clots In Lung (PE) Or Legs (DVT) Are Cases That Can Get Settlements
While These Claims Against Bayer Are Lesser Known Than YAZ / Yasmin / Ocella Lawsuits They Are Essentially The Same Type Of Drug Injury Legal Claim
YAZ, Yasmin, Ocella, Gianvi, Beyaz, and Safyral are birth control pills containing drospirenone (DRSP). These oral contraceptives have been associated with a possible increased risk of blood clots and potentially fatal adverse events such as deep vein thrombosis (DVT), pulmonary embolism (PE), strokes (CVA), and heart attacks or myocardial infarctions (MI).
Serious Bleeding Events • Hemorrhages • Heart Attack or Myocardial Infarction (MI) • Acute Coronary Syndrome (ACS)
Pradaxa is a blood-thinning drug used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem. Since coming on the market in October 2010 the FDA has received numerous Adverse Event Reports involving serious bleeding side effects such as hemorrhages. Further, medical studies have associated Pradaxa with an increased risk of heart attacks, or myocardial infarctions (MI), and acute coronary syndrome (ACS).
Heart Attack • Stroke • Blood Clots • Deep Vein Thrombosis (DVT) • Pulmonary Embolism (PE)
June 2013 NuvaRing Update: Significant Legal And Medical Developments From Past Year As Reported In Recent Articles
Number Of NuvaRing Lawsuits Filed Against Merck Increases, And New Evidence That NuvaRing Causes Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), And Blood Clots
NuvaRing is a birth control product in the form of a vaginal ring containing hormones similar to those in oral contraceptives. NuvaRing has been associated with increased risk of blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as strokes (CVA) and heart attacks or myocardial infarctions (MI).
Osteonecrosis of Jaw (ONJ) • Femur Fractures (Low-Stress Breaks of Thigh Bone)
Merck Continues To Dispute Scheinberg Fosamax Plaintiff Verdict At June 2013 Hearing Before Judge Keenan Concerning The ONJ Warnings Aspect Of Case
Fosamax (alendronate), which is used to treat osteoporosis, has been associated with low-stress or atypical fractures of the femur / thigh bone. Fosamax has also been associated with osteonecrosis of the jaw, or jaw bone death, commonly referred to as ONJ.
Cardiopulmonary / Cardiac Arrest • Heart Attack • Sudden Cardiac Death • Stroke (CVA) • Alkalosis
Fresenius GranuFlo Product Has Been Associated With Heart Problems And Cardiopulmonary Arrest During Dialysis Treatment
The dialysis product GranuFlo from Fresenius was used by approximately one-third of the 400,000 patients with late-stage kidney failure requiring dialysis per year at a time when Fresenius apparently knew that GranuFlo caused an increased risk of metabolic alkalosis that could result in cardiopulmonary arrest, sudden heart attack, stroke, or death.
Liver Damage • Liver Failure • Liver Transplant • Renal Impairment • Kidney Damage • Heart Failure • Cardiovascular Death • Stroke • Institial Lung Disease (ILD) • Pulmonary Fibrosis • Pneumonitis
Multaq (dronedarone) is a drug used to treat abnormal heart rhythm (atrial fibrillation or atrial flutter). In September 2012 the FDA approved label changes for Multaq, including one about certain types of lung disease such as pneumonitis and pulmonary fibrosis being serious side effects of Multaq use. In December 2011 the FDA said Multaq increased the risk of serious cardiovascular events, including death, when used by patients in permanent atrial fibrillation (AF). In July 2011 the FDA said some clinical trial data showed a two-fold increase in death, as well as a two-fold increases in stroke (CVA) and hospitalization for heart failure in patients receiving Multaq compared to a placebo. In January 2011 the FDA issued a drug safety alert for Multaq concerning severe liver injury, such as liver failure requiring liver transplantation, associated with Multaq use. Lastly, cases of renal impairment and kidney damage in patients using Multaq have been reported.
Pancreatitis: Acute / Hemorrhagic / Necrotizing • Kidney Failure • Renal Insuffiency
Cancer of The Pancreas: Possible Side Effect For Diabetics Who Use Byetta, Januvia, Or Victoza?
Byetta (exenatide) is an injection drug used by adults with type 2 diabetes mellitus. This diabetes medication has been associated with damage to the pancreas -- acute pancreatitis, hemorrhagic pancreatitis, or necrotizing pancreatitis -- as well as severe kidney problems, including kidney failure and renal insufficiency.
Liver Damage • Liver Failure • Liver Transplant
Ketek (telithromycin) is an antibiotic that has been associated with serious liver problems such as drug-induced hepatitis and liver failure, which can result in the need for a liver transplant.
All content by attorney Tom Lamb
Visit DrugInjuryWatch.com and see why some of attorney Tom Lamb's articles have been featured on these sites:
Recent Drug Injury Watch Posts
Merck Faces More Than 4100 Fosamax - Femur Fracture Lawsuits As Of September 30, 2013 According To SEC Corporate Filing
Next Bellwether Trial Dates: In New Jersey, One To Three Cases Set For March 2014; And, In Fosamax Federal Court MDL, One Case Set For May 2014
SUMMARY: From the Merck SEC Form 10-Q for the quarterly period ended September 30, 2013:
•... plaintiffs in approximately 4,115 of these actions generally allege that they sustained femur fractures and/or other bone injuries (“Femur Fractures”) in association with the use of Fosamax.
•... approximately 1,085 cases were pending in the Fosamax Femur Fracture MDL as of September 30, 2013.
•As of September 30, 2013, approximately 2,520 cases alleging Femur Fractures have been filed in New Jersey state court and are pending before Judge Higbee in Atlantic County Superior Court.
We will continue to monitor the Fosamax - femur fracture litigation and report significant developments.
[Read this article in full at original source]
Earlier articles by attorney Tom Lamb on the Drug Injury Watch blog:
List of Latest Case Evaluations
Gianvi - Pulmonary Embolism (PE) - 25 yr old woman (7999)
Beyaz - Stroke (CVA) - 48 yr old woman (7997)
Safyral - Pulmonary Embolism (PE) - 39 yr old woman (7988)
Ocella - Pulmonary Embolism (PE) - 23 yr old woman (7984)
NuvaRing - Multiple Blood Clots in Brain - 20 yr old woman (7973)
NuvaRing - Deep Vein Thrombosis (DVT); required later surgery on vein - 44 yr old woman (7972)
Zometa - Osteomyolitis / Osteonecrosis of the Jaw (ONJ) - 58 yr old woman (7965)
Pradaxa - Gastrointestinal (GI) Bleed - 74 yr old man (7956)
Cipro - Retinal Detachment; after two unsuccessful surgeries, now totally blind in one eye (7947)
NuvaRing - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) - 26 yr old woman (7944)
Ocella - Deep Vein Thrombosis (DVT) - 31 yr old woman (7940)
Boniva and Fosamax - Atypical Stress Fracture of Femur - 57 yr old woman (7939)
Boniva - Femur Fracture - 56 yr old woman (7938)
GranuFlo - Stroke (CVA); 4 months hospitalization - 56 yr old man (7932)
Multaq - Interstitial Lung Disease (ILD) resulting in Death - 84 yr old woman (7919)
Levaquin - Eye / Vision Problems and Vitreous Detachments - 28 yr old man (7903)
Gianvi - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) - 28 yr old woman (7900)
Fosamax - Osteonecrosis of the Jaw (ONJ) - 77 yr old woman (7897)
Gianvi - Deep Vein Thrombosis (DVT) - 28 yr old woman (7893)
Ocella - Deep Vein Thrombosis (DVT) - 19 yr old woman (7892)
Safyral - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) - 33 yr old woman (7888)
Beyaz - Stroke - 23 yr old woman (7879)
NuvaRing - Pulmonary Embolism (PE) - 18 yr old woman (7873)
NuvaRing - Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) - 35 yr old woman (7872)
Gianvi - Pulmonary Embolism (PE) - 22 yr old woman (7871)
Gianvi - Deep Vein Thrombosis (DVT); blood clot calcified, will alwawys be in the vein - 32 yr old woman (7870)
Gianvi - Deep Vein Thrombosis (DVT) - 19 yr old woman (7869)
Learn More About How We Work
Law Offices of Thomas J. Lamb, P.A.
Here to Help. From Start to Finish.
We know that you have options when it comes to finding the right law firm to handle your case.
On our FAQ page we provide answers to some questions prospective clients often ask us when making their decision about hiring a law firm.